Your browser doesn't support javascript.
loading
Maternal SARS-CoV-2 infection in pregnancy disrupts gene expression in Hofbauer cells with limited impact on cytotrophoblasts.
Enninga, Elizabeth Ann L; Quach, Huy Quang; Jang, Jin Sung; de Araujo Correia, Maria Cristina Miranda; Fedyshyn, Yaroslav; Fedyshyn, Bohdana; Lemens, Maureen; Littlefield, Dawn; Behl, Supriya; Sintim-Aboagye, Elise; Mejia Plazas, Maria C; Cardenas, Maria C; Chakraborty, Shree; Yamaoka, Satoko; Ebihara, Hideki; Pandey, Akhilesh; Li, Hu; Badley, Andrew D; Johnson, Erica L; Sun, Jie; Norgan, Andrew P; Theiler, Regan N; Chakraborty, Rana.
Afiliação
  • Enninga EAL; Department of Obstetrics and Gynecology, Mayo Clinic, Rochester, Minnesota, United States of America.
  • Quach HQ; Department of Immunology, Mayo Clinic, Rochester, Minnesota, United States of America.
  • Jang JS; Mayo Clinic Vaccine Research Group, Department of Internal Medicine, Mayo Clinic, Rochester, Minnesota, United States of America.
  • de Araujo Correia MCM; Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, Minnesota, United States of America.
  • Fedyshyn Y; Department of Molecular Pharmacology and Experimental Therapeutics, Mayo Clinic, Rochester, Minnesota, United States of America.
  • Fedyshyn B; Children Research Center, Division of Pediatric Infectious Diseases, Department of Pediatric and Adolescent Medicine, Mayo Clinic, Rochester, Minnesota, United States of America.
  • Lemens M; Department of Obstetrics and Gynecology, Mayo Clinic, Rochester, Minnesota, United States of America.
  • Littlefield D; Department of Obstetrics and Gynecology, Mayo Clinic, Rochester, Minnesota, United States of America.
  • Behl S; Children Research Center, Division of Pediatric Infectious Diseases, Department of Pediatric and Adolescent Medicine, Mayo Clinic, Rochester, Minnesota, United States of America.
  • Sintim-Aboagye E; Children Research Center, Division of Pediatric Infectious Diseases, Department of Pediatric and Adolescent Medicine, Mayo Clinic, Rochester, Minnesota, United States of America.
  • Mejia Plazas MC; Children Research Center, Division of Pediatric Infectious Diseases, Department of Pediatric and Adolescent Medicine, Mayo Clinic, Rochester, Minnesota, United States of America.
  • Cardenas MC; Children Research Center, Division of Pediatric Infectious Diseases, Department of Pediatric and Adolescent Medicine, Mayo Clinic, Rochester, Minnesota, United States of America.
  • Chakraborty S; Children Research Center, Division of Pediatric Infectious Diseases, Department of Pediatric and Adolescent Medicine, Mayo Clinic, Rochester, Minnesota, United States of America.
  • Yamaoka S; Children Research Center, Division of Pediatric Infectious Diseases, Department of Pediatric and Adolescent Medicine, Mayo Clinic, Rochester, Minnesota, United States of America.
  • Ebihara H; Department of Molecular Medicine, Mayo Clinic, Rochester, Minnesota, United States of America.
  • Pandey A; Department of Molecular Medicine, Mayo Clinic, Rochester, Minnesota, United States of America.
  • Li H; Department of Laboratory Medicine and Pathology, Division of Clinical Biochemistry and Immunology, Mayo Clinic, Rochester, Minnesota, United States of America.
  • Badley AD; Center for Molecular Medicine, National Institute of Mental Health and Neurosciences, Bangalore, Karnataka, India.
  • Johnson EL; Center for Individualized Medicine, Mayo Clinic, Rochester, Minnesota, United States of America.
  • Sun J; Department of Molecular Pharmacology and Experimental Therapeutics, Mayo Clinic, Rochester, Minnesota, United States of America.
  • Norgan AP; Division of Infectious Diseases, Department of Medicine, Mayo Clinic, Rochester, Minnesota, United States of America.
  • Theiler RN; Department of Microbiology, Biochemistry, and Immunology, Morehouse School of Medicine, Atlanta, Georgia, United States of America.
  • Chakraborty R; Thoracic Diseases Research Unit, Division of Pulmonary and Critical Care Medicine, Department of Medicine, Department of Immunology, Mayo Clinic College of Medicine and Science, Rochester, Minnesota, United States of America.
PLoS Pathog ; 20(2): e1011990, 2024 Feb.
Article em En | MEDLINE | ID: mdl-38324589
ABSTRACT

BACKGROUND:

Hofbauer cells (HBCs) and cytotrophoblasts (CTBs) are major cell populations in placenta. The indirect impact of maternal SARS-CoV-2 disease on these cells that are not directly infected has not been extensively studied. Herein, we profiled gene expression in HBCs and CTBs isolated from placentae of recovered pregnant subjects infected with SARS-CoV-2 during all trimesters of pregnancy, placentae from subjects with active infection, SARS-CoV-2 vaccinated subjects, and those who were unexposed to the virus.

METHODS:

Placentae were collected within 4 h post-delivery and membrane-free tissues were enzymatically digested for the isolation of HBCs and CTBs. RNA extracted from HBCs and CTBs were sequenced using 150bp paired-end reads. Differentially expressed genes (DEGs) were identified by DESeq2 package in R and enriched in GO Biological Processes, KEGG Pathway, Reactome Gene Sets, Hallmark Gene Sets, and Canonical Pathways. Protein-protein interactions among the DEGs were modelled using STRING and BioGrid.

RESULTS:

Pregnant subjects (n = 30) were recruited and categorized into six groups infected with SARS-CoV-2 in i) the first (1T, n = 4), ii) second (2T, n = 5), iii) third (3T, n = 5) trimester, iv) tested positive at delivery (Delivery, n = 5), v) never infected (Control, n = 6), and vi) fully mRNA-vaccinated by delivery (Vaccinated, n = 5). Compared to the Control group, gene expression analysis showed that HBCs from infected subjects had significantly altered gene expression profiles, with the 2T group having the highest number of DEGs (1,696), followed by 3T and 1T groups (1,656 and 958 DEGs, respectively). These DEGs were enriched for pathways involved in immune regulation for host defense, including production of cytokines, chemokines, antimicrobial proteins, ribosomal assembly, neutrophil degranulation inflammation, morphogenesis, and cell migration/adhesion. Protein-protein interaction analysis mapped these DEGs with oxidative phosphorylation, translation, extracellular matrix organization, and type I interferon signaling. Only 95, 23, and 8 DEGs were identified in CTBs of 1T, 2T, and 3T groups, respectively. Similarly, 11 and 3 DEGs were identified in CTBs and HBCs of vaccinated subjects, respectively. Reassuringly, mRNA vaccination did not induce an inflammatory response in placental cells.

CONCLUSIONS:

Our studies demonstrate a significant impact of indirect SARS-CoV-2 infection on gene expression of inner mesenchymal HBCs, with limited effect on lining CTB cells isolated from pregnant subjects infected and recovered from SARS-CoV-2. The pathways associated with these DEGs identify potential targets for therapeutic intervention.
Assuntos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Placenta / COVID-19 Limite: Female / Humans / Pregnancy Idioma: En Ano de publicação: 2024 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Placenta / COVID-19 Limite: Female / Humans / Pregnancy Idioma: En Ano de publicação: 2024 Tipo de documento: Article